AHA Scientific Sessions 2025 Abstract

Overcoming Barriers For Research Participation In Minority Patients In Lp(a)FRONTIERS EXPANSION: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate Efficacy And Safety Of Pelacarsen In U.S. Black And Hispanic Patients with Elevated Lp(a) And Established ASCVD

Trial in peopleInterventions

The paper

Tulane University; Wake Forest University Health Sciences

AHA Scientific Sessions 2025 Abstract, 3 Nov 2025

Presented at AHA Scientific Sessions 2025, abstract 4365650

doi.org/10.1161/circ.152.suppl_3.4365650